374 related articles for article (PubMed ID: 29680106)
1. Cost of Tuberculosis Diagnosis and Treatment in Patients with HIV: A Systematic Literature Review.
de Siqueira-Filha NT; Legood R; Cavalcanti A; Santos AC
Value Health; 2018 Apr; 21(4):482-490. PubMed ID: 29680106
[TBL] [Abstract][Full Text] [Related]
2. Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis.
Uppal A; Rahman S; Campbell JR; Oxlade O; Menzies D
PLoS Med; 2021 Sep; 18(9):e1003712. PubMed ID: 34520463
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of Initiating Antiretroviral Therapy at Different Points in TB Treatment in HIV-TB Coinfected Ambulatory Patients in South Africa.
Naidoo K; Grobler AC; Deghaye N; Reddy T; Gengiah S; Gray A; Abdool Karim S
J Acquir Immune Defic Syndr; 2015 Aug; 69(5):576-84. PubMed ID: 26167618
[TBL] [Abstract][Full Text] [Related]
4. Computer-aided X-ray screening for tuberculosis and HIV testing among adults with cough in Malawi (the PROSPECT study): A randomised trial and cost-effectiveness analysis.
MacPherson P; Webb EL; Kamchedzera W; Joekes E; Mjoli G; Lalloo DG; Divala TH; Choko AT; Burke RM; Maheswaran H; Pai M; Squire SB; Nliwasa M; Corbett EL
PLoS Med; 2021 Sep; 18(9):e1003752. PubMed ID: 34499665
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study.
Azadi M; Bishai DM; Dowdy DW; Moulton LH; Cavalcante S; Saraceni V; Pacheco AG; Cohn S; Chaisson RE; Durovni B; Golub JE
Int J Tuberc Lung Dis; 2014 Dec; 18(12):1443-8. PubMed ID: 25517809
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis screening in high human immunodeficiency virus prevalence settings: turning promise into reality.
Corbett EL; MacPherson P
Int J Tuberc Lung Dis; 2013 Sep; 17(9):1125-38. PubMed ID: 23928165
[TBL] [Abstract][Full Text] [Related]
7. Cost utility of lateral-flow urine lipoarabinomannan for tuberculosis diagnosis in HIV-infected African adults.
Sun D; Dorman S; Shah M; Manabe YC; Moodley VM; Nicol MP; Dowdy DW
Int J Tuberc Lung Dis; 2013 Apr; 17(4):552-8. PubMed ID: 23485389
[TBL] [Abstract][Full Text] [Related]
8. The economic burden of tuberculosis and latent tuberculosis in people living with HIV in Brazil: a cost study from the patient perspective.
de Siqueira Filha NT; de Fatima Pessoa Militao de Albuquerque M; Legood R; Rodrigues L; Santos AC
Public Health; 2018 May; 158():31-36. PubMed ID: 29533835
[TBL] [Abstract][Full Text] [Related]
9. The cost of intensified case finding and isoniazid preventive therapy for HIV-infected patients in Battambang, Cambodia.
Sutton BS; Arias MS; Chheng P; Eang MT; Kimerling ME
Int J Tuberc Lung Dis; 2009 Jun; 13(6):713-8. PubMed ID: 19460246
[TBL] [Abstract][Full Text] [Related]
10. Results of rapid and successful integration of HIV diagnosis and care into tuberculosis services in Benin.
Ferroussier O; Dlodlo RA; Capo-Chichi D; Boillot F; Gninafon M; Trébucq A; Fujiwara PI
Int J Tuberc Lung Dis; 2013 Nov; 17(11):1405-10. PubMed ID: 24125442
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinicaly screened for latent tuberculosis infection in Dar es Salaam, Tanzania: A prospective Cohort study.
Shayo GA; Chitama D; Moshiro C; Aboud S; Bakari M; Mugusi F
BMC Public Health; 2017 Jul; 18(1):35. PubMed ID: 28724374
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the economic burden of diagnosis and treatment of tuberculosis patients in rural China.
Pan HQ; Bele S; Feng Y; Qiu SS; Lü JQ; Tang SW; Shen HB; Wang JM; Zhu LM
Int J Tuberc Lung Dis; 2013 Dec; 17(12):1575-80. PubMed ID: 24200271
[TBL] [Abstract][Full Text] [Related]
13. Free tuberculosis diagnosis and treatment are not enough: patient cost evidence from three continents.
Mauch V; Bonsu F; Gyapong M; Awini E; Suarez P; Marcelino B; Melgen RE; Lönnroth K; Nhung NV; Hoa NB; Klinkenberg E
Int J Tuberc Lung Dis; 2013 Mar; 17(3):381-7. PubMed ID: 23407227
[TBL] [Abstract][Full Text] [Related]
14. Sharing the burden of TB/HIV? Costs and financing of public-private partnerships for tuberculosis treatment in South Africa.
Sinanovic E; Kumaranayake L
Trop Med Int Health; 2006 Sep; 11(9):1466-74. PubMed ID: 16930269
[TBL] [Abstract][Full Text] [Related]
15. The economic burden of tuberculosis care for patients and households in Africa: a systematic review.
Ukwaja KN; Modebe O; Igwenyi C; Alobu I
Int J Tuberc Lung Dis; 2012 Jun; 16(6):733-9. PubMed ID: 22410546
[TBL] [Abstract][Full Text] [Related]
16. Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.
Laurence YV; Griffiths UK; Vassall A
Pharmacoeconomics; 2015 Sep; 33(9):939-55. PubMed ID: 25939501
[TBL] [Abstract][Full Text] [Related]
17. Incremental Cost Effectiveness of Bedaquiline for the Treatment of Rifampicin-Resistant Tuberculosis in South Africa: Model-Based Analysis.
Schnippel K; Firnhaber C; Conradie F; Ndjeka N; Sinanovic E
Appl Health Econ Health Policy; 2018 Feb; 16(1):43-54. PubMed ID: 28980217
[TBL] [Abstract][Full Text] [Related]
18. Cost of three models of care for drug-resistant tuberculosis patients in Nigeria.
Bada FO; Okpokoro E; Blok N; Meribole E; Dutt S; Dakum P; Abimiku A; Zwerling A; Kik SV
BMC Infect Dis; 2019 Jan; 19(1):41. PubMed ID: 30630429
[TBL] [Abstract][Full Text] [Related]
19. Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach?
Loeliger A; Suthar AB; Ripin D; Glaziou P; O'Brien M; Renaud-Thery F; Crowley S; Williams B; Ridzon R; Granich R; Gilks C
Int J Tuberc Lung Dis; 2012 Jan; 16(1):6-15. PubMed ID: 21819645
[TBL] [Abstract][Full Text] [Related]
20. Integrating HIV testing and care into tuberculosis services in Benin: programmatic aspects.
Ferroussier O; Dlodlo RA; Capo-Chichi D; Boillot F; Gninafon M; Trébucq A; Fujiwara PI
Int J Tuberc Lung Dis; 2013 Nov; 17(11):1402-4. PubMed ID: 24125441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
